AdPha warns of health system growth disconnect
ADVANCED Pharmacy Australia (AdPha) has welcomed news of this year’s record intake of graduate doctors into the Queensland health system,…
Wegovy gets the nod, Shingrix age lowering knocked back
IN THE outcomes of its November meeting released at the end of last year, the Pharmaceutical Benefits Advisory Committee (PBAC)…
PD for Tue 06 Jan 2026
AdPha warns of health system growth vs workforce disconnect, more menopause options for PBS listing, weight loss jabs’ downsides downplayed,…
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Ōura’s Ricky Bloomfield proposes new regulatory pathway for wearable health features
The chief medical officer is interested in an easier path to market for health screening features in wearable devices.
FDA approves therapy for rare blood disorder in pediatric patients 12 years and older
The U.S. Food and Drug Administration approved Cablivi (caplacizumab-yhdp) for injection to treat pediatric patients 12 years and older with…
FDA approves first drug to treat serious complication of stem cell transplant
The U.S. Food and Drug Administration (FDA) approved Yartemlea (narsoplimab-wuug) injection to treat adults and children 2 years and older…
FDA approves first oral treatment for anemia in thalassemia, an inherited blood disorder
The U.S. Food and Drug Administration (FDA) approved Aqvesme (mitapivat) tablets to treat anemia (low levels of red blood cells)…